x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

Safer, Smarter, Faster

Clinical Research for

Research Sites Sponsors Academia CROs

We advance clinical research by enabling the research ecosystem to develop life-changing therapies

Learn More

Advarra Integrated Solutions enable the safe, ethical, compliant, and efficient development of life-changing therapies.

Premier provider of integrated IRB, IBC, DMC, and EAC review services.
  • Largest integrated provider of Institutional Review Board (IRB) services covering a network of more than 3,500 health systems, cancer centers, academic medical centers, and investigators.
  • Powered by the Center for IRB Intelligence Platform (CIRBI).
  • Largest provider of IBC services supported by a growing network of Gene Therapy Ready sites.
  • Industry’s most experienced provider of DMC and EAC services powered by a worldwide network of 1,500+ medical, biostatistical, and clinical research experts.

Learn More

Solve mission-critical challenges and bring life-changing therapies to patients faster
  • Team of expert consultants, organized in Centers of Excellence specializing in Quality, Regulatory, Clinical, and Institutional Research.
  • Effectively blending industry best practice; tested, proven methodologies
  • Successful history of client engagements to deliver optimal outcomes.​

Learn More About Consulting

Globe depicting Advarra Consulting connections

Large team and standard processes provide fast, reliable services and real results
  • Streamline your study activation and research productivity.
  • Maximize your Advarra technology investments.
  • Experience breakthrough efficiencies.

Learn More

Next-generation technology solutions that automate, streamline, and expedite processes across the clinical trial lifecycle
  • Solutions for Sponsors and CROs improve study start up and simplify and provide greater visibility to submission, tracking and review processes and support site and patient education and protocol compliance.
  • Solutions for sites deliver comprehensive visibility into research operations, increased financial viability, enhanced compliance across the research enterprise, and improved strategic decision-making.

Learn More

Customer Community Across The Clinical Research Ecosystem

We Accelerate the Advancement of Human Health

Safeguard Trial Participants

Advarra safeguards trial participants by ensuring protocols are safe for the patient and feasible for researchers.

Learn More
Learn More

Ensure Compliance

Advarra provides innovative regulatory compliance solutions and expertise throughout the research lifecycle.

Learn More
Learn More

Empower Clinical Sites

Advarra applies site-centric technologies to facilitate critical workflows and collaboration between sites, sponsors, and CROs.

Learn More
Learn More

Optimize Research Performance

From strategic program and study design, to site selection, to conducting trials, Advarra’s data-driven approach and clinical, quality, regulatory, and therapeutic expertise makes us invaluable partners.

Learn More
Learn More

Advarra By the Numbers

3,500+

institutions, hospitals, health systems, and academic medical centers trust Advarra

100%

of Operation Warp Speed vaccine trials supported by Advarra IRB and IBC

78%

NCI-designated Cancer Centers use Advarra Technology

50,000

investigators utilize Advarra technology solutions to support their research

Read our Related Resources

 
Blog

Your Guide to sIRB Mandates

sIRB regulations and policies have been announced and implemented to help address the challenges of conducting clinical trials involving multiple research sites.

Read Now
4 min. read
Read more
 
Blog

Why Keep HIPAA Separate from the Informed Consent Form

HIPAA is important to the informed consent process, and oftentimes, a standalone document is the most beneficial approach.

Read Now
5 min. read
Read more
 
Blog

Regulatory Trends in Cell and Gene Therapies

Recent signals have indicated the FDA plans to provide greater support for cell and gene therapy research.

Read Now
6 min. read
Read more

Visit the Resource Library

Get Started